JP2014510590A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014510590A5 JP2014510590A5 JP2014501668A JP2014501668A JP2014510590A5 JP 2014510590 A5 JP2014510590 A5 JP 2014510590A5 JP 2014501668 A JP2014501668 A JP 2014501668A JP 2014501668 A JP2014501668 A JP 2014501668A JP 2014510590 A5 JP2014510590 A5 JP 2014510590A5
- Authority
- JP
- Japan
- Prior art keywords
- combination product
- composition
- product
- composition according
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161470211P | 2011-03-31 | 2011-03-31 | |
| US61/470,211 | 2011-03-31 | ||
| PCT/EP2012/055979 WO2012131095A1 (en) | 2011-03-31 | 2012-04-02 | Compositions comprising a filler product and at least one bioresorbable and biodegradable silica-based material |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014510590A JP2014510590A (ja) | 2014-05-01 |
| JP2014510590A5 true JP2014510590A5 (https=) | 2015-05-21 |
Family
ID=45953116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014501668A Pending JP2014510590A (ja) | 2011-03-31 | 2012-04-02 | フィラー製品および少なくとも１つの生体吸収性および生分解性シリカベースの材料を含む組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20140065221A1 (https=) |
| EP (1) | EP2691115A1 (https=) |
| JP (1) | JP2014510590A (https=) |
| BR (1) | BR112013025157A2 (https=) |
| CA (1) | CA2830654A1 (https=) |
| WO (1) | WO2012131095A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9023896B2 (en) | 2009-05-04 | 2015-05-05 | Psivida Us, Inc. | Porous silicon drug-eluting particles |
| CN103282020B (zh) | 2010-11-01 | 2016-10-26 | 普西维达公司 | 用于递送治疗剂的可生物侵蚀的硅基装置 |
| WO2014151381A1 (en) | 2013-03-15 | 2014-09-25 | Psivida Us, Inc. | Bioerodible silicon-based compositions for delivery of therapeutic agents |
| KR101647182B1 (ko) * | 2014-02-10 | 2016-08-23 | 박용호 | 피부조직 복원용 필러엑스(Filler X) 조성물 |
| EP4670750A3 (en) * | 2017-06-12 | 2026-03-04 | Advanced Aesthetic Technologies, Inc. | Dermal filler |
| CA3099732A1 (en) | 2018-05-09 | 2019-11-14 | The Johns Hopkins University | Nanofiber-hydrogel composites for cell and tissue delivery |
| ES3060255T3 (en) | 2018-05-09 | 2026-03-25 | Univ Johns Hopkins | Nanofiber-hydrogel composites for enhanced soft tissue replacement and regeneration |
| KR102264957B1 (ko) * | 2019-06-21 | 2021-06-17 | 고려대학교 산학협력단 | 체내 부피 유지 제제 및 이의 제조방법 |
| WO2020256340A2 (ko) * | 2019-06-21 | 2020-12-24 | 고려대학교산학협력단 | 체내 부피 유지 제제, 이를 포함하는 주사제 및 이의 제조방법 |
| JP2025041170A (ja) * | 2023-09-13 | 2025-03-26 | 昌毅 本田 | 肛門狭窄化治療法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4777041A (en) * | 1986-08-07 | 1988-10-11 | Charles Of The Ritz Group Ltd. | Wrinkle treatment formulation |
| US5204382A (en) * | 1992-02-28 | 1993-04-20 | Collagen Corporation | Injectable ceramic compositions and methods for their preparation and use |
| JP2588109B2 (ja) * | 1993-03-19 | 1997-03-05 | 日本臓器製薬株式会社 | 鎮痛剤 |
| US5599852A (en) * | 1994-10-18 | 1997-02-04 | Ethicon, Inc. | Injectable microdispersions for soft tissue repair and augmentation |
| US5827937A (en) | 1995-07-17 | 1998-10-27 | Q Med Ab | Polysaccharide gel composition |
| DE19609551C1 (de) | 1996-03-12 | 1997-07-17 | Fraunhofer Ges Forschung | Biologisch degradierbare und/oder biologisch resorbierbare (Endlos)Fasern, Verfahren zu deren Herstellung und deren Verwendung als Verstärkungsfasern |
| US6726932B2 (en) * | 2000-02-18 | 2004-04-27 | Nippon Zoki Pharmaceutical Co., Ltd. | Fatty acid-containing composition |
| US20040047892A1 (en) * | 2000-11-15 | 2004-03-11 | Desrosiers Eric Andre | Filler composition for soft tissue augmentation and reconstructive surgery |
| DE102007061873B4 (de) | 2007-01-15 | 2025-06-26 | Bayer Intellectual Property Gmbh | Kieselsol-Material zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien, dessen Herstellung und Verwendung |
| EP2211868B1 (en) * | 2007-10-15 | 2017-08-02 | 7 Oaks Pharmaceutical Corporation | Silicate containing compositions for the treatment of melanoma |
| DE102008033327A1 (de) * | 2008-07-16 | 2010-01-21 | Bayer Innovation Gmbh | Kieselsol-Material mit mindestens einem therapeutisch aktiven Wirkstoff zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien für die Humanmedizin und/oder Medizintechnik |
| DE102010008981A1 (de) * | 2010-02-24 | 2011-08-25 | Bayer Innovation GmbH, 40225 | Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie |
-
2012
- 2012-04-02 EP EP12713943.4A patent/EP2691115A1/en not_active Withdrawn
- 2012-04-02 BR BR112013025157A patent/BR112013025157A2/pt not_active IP Right Cessation
- 2012-04-02 CA CA2830654A patent/CA2830654A1/en not_active Abandoned
- 2012-04-02 US US14/006,745 patent/US20140065221A1/en not_active Abandoned
- 2012-04-02 JP JP2014501668A patent/JP2014510590A/ja active Pending
- 2012-04-02 WO PCT/EP2012/055979 patent/WO2012131095A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014510590A5 (https=) | ||
| JP2012529484A5 (ja) | 高血圧症の防止及び治療のための組成物並びに方法 | |
| MY171929A (en) | Corticosteroids for the treatment of joint pain | |
| EP3861982A3 (en) | Intracameral implant for treatment of an ocular condition | |
| JP2012529488A5 (https=) | ||
| AR084932A1 (es) | Composicion oftalmica que comprende un androgeno y su uso para la fabricacion de un medicamento util para el tratamiento de una enfermedad ocular resultante de una deficiencia androgenica | |
| AR071968A1 (es) | Uso de un oligosacarido en el tratamiento de la inflamacion intestinal | |
| MX2022003132A (es) | Composiciones de corticoesteroides administradas oralmente. | |
| MX2014004458A (es) | Hebra de acido hialuronico reticulado y metodos de uso de las mismas. | |
| HRP20160427T1 (hr) | Fitokanabinoidi u liječenju raka | |
| JP2013517263A5 (https=) | ||
| WO2009109613A3 (en) | 1-BENZYL-3-HYDROXYMETHYLINDAZOIιE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1, CX3CR1 | |
| CO6311006A2 (es) | Composicion farmaceutica que comprende un agente que activa las celulas t regulatorias cd4+cd25+ efectiva a dosis altas | |
| HK1206270A1 (en) | Controlled release formulations for the delivery of hif-1 inhibitors | |
| BR112014029206A2 (pt) | pós hemostáticos de celulose regenerada oxidada e métodos para fabricação dos mesmos | |
| GT201200281A (es) | Formas de dosificación sólidas orales con dosis muy bajas para la hrt | |
| WO2011148116A3 (fr) | Acide hyaluronique modifie, procede de fabrication et utilisations | |
| MX365650B (es) | Composiciones de amantadina y metodos para su uso. | |
| WO2009109616A8 (en) | 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 | |
| NZ631429A (en) | Porous carbon particles for use in the treatment or prevention of liver disease | |
| NZ595904A (en) | A novel formulation of meloxicam | |
| AR077125A1 (es) | Combinaciones farmaceuticas utiles para tratar el vhc | |
| MX2010009624A (es) | Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1 y cx3cr1. | |
| WO2015019304A3 (fr) | Compositions à libération continue à base d'acide hyaluronique, et leurs applications thérapeutiques | |
| MX343243B (es) | Control de aldehidos en productos de cuidado personal. |